Clinical trial · Interventional
Radiofrequency Ablation in Treating Patients Who Are Undergoing Surgery for Thyroid Cancer
Radiofrequency Ablation for Low Risk Papillary Thyroid Cancer: A Pilot Study
NCT00103155CI-TRIAL-00012248unknownPhase 1ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
RATIONALE: Radiofrequency ablation uses a high-frequency, electric current to kill tumor cells. Ultrasound-guided radiofrequency ablation may be effective treatment for thyroid cancer. PURPOSE: This phase I trial is studying the side effects of radiofrequency ablation in treating patients who are undergoing surgery for thyroid cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Head and Neck Cancer | Malignant Head and Neck Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| conventional surgery | Procedure | — | UNRESOLVED |
| radiofrequency ablation | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Frequency of radiofrequency ablation-associated complications at 2 weeks
Secondary outcomes (1)
- measure
- Amount of tumor destruction at 2 weeks
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 21 Years
Show eligibility criteria text
DISEASE CHARACTERISTICS: * Cytologically confirmed papillary thyroid cancer by fine needle aspiration * Low-risk disease * No poorly differentiated cytology * Intrathyroidal tumor * Located within the anterior two-thirds of the thyroid lobe * Tumor not adjacent to the trachea by neck ultrasound * Tumor ≤ 1.5 cm by neck ultrasound * Requires thyroidectomy * No cervical lymphadenopathy * No multicentric tumors by neck ultrasound * No evidence of lymph node metastasis PATIENT CHARACTERISTICS: Age * Over 21 Performance status * Not specified Life expectancy * Not specified Hematopoietic * Not specified Hepatic * Not specified Renal * Not specified PRIOR CONCURRENT THERAPY: Biologic therapy * Not specified Chemotherapy * Not specified Endocrine therapy * Not specified Radiotherapy * Not specified Surgery * Not specified
References
Publications (0)
Data not yet available
No reference posted for this study.